Search Within

Charlotte Eielson Ariyan

  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (19)
  2. Meeting Abstract (19)
  3. Miscellaneous (1)
  4. Research Letter (1)
Groups
  1. Epidemiology and Biostatistics (40)
  2. Melanoma Disease Management Team (40)
  3. Surgery (40)
  4. Biostatistics Service (37)
  5. Survivorship Research (31)
  6. Department of Medicine (29)

More Groups

People
  1. Daniel Coit (27)
  2. Katherine Panageas (26)
  3. Mary Brady (24)
  4. Jedd Wolchok (14)
  5. Michael Postow (14)
  6. Alexander Shoushtari (10)

More People

Years
  1. 2024 (1)
  2. 2023 (1)
  3. 2021 (4)
  4. 2020 (6)
  5. 2019 (4)
  6. 2018 (5)

More Years

Publications
  1. Annals of Surgical Oncology (17)
  2. Journal of Clinical Oncology (10)
  3. Annals of Behavioral Medicine (1)
  4. Cancer (1)
  5. Cancer Discovery (1)
  6. Cancer Immunology Research (1)

More Publications

Publishers
  1. Springer (18)
  2. American Society of Clinical Oncology (10)
  3. American Association for Cancer Research (3)
  4. Elsevier Inc. (2)
  5. Nature Publishing Group (2)
  6. American Medical Association (1)

More Publishers

Results (40)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Robust antitumor responses result from local chemotherapy and CTLA-4 blockade
    Journal Article

    Ariyan, C. E.; Brady, M. S.; Siegelbaum, R. H.; Hu, J.; Bello, D. M.; Rand, J.; Fisher, C.; Lefkowitz, R. A.; Panageas, K. S.; Pulitzer, M.; more...
    Cancer Immunology Research (2018)

    Fulltext@MSK | Save
  • Four-month course of adjuvant dabrafenib in patients with surgically resected stage IIIC melanoma characterized by a BRAFV600E/K mutation
    Journal Article

    Momtaz, P.; Harding, J. J.; Ariyan, C.; Coit, D. G.; Merghoub, T.; Gasmi, B.; You, D.; Viale, A.; Panageas, K. S.; Samoila, A.; more...
    Oncotarget (2017)

    Fulltext@MSK | Save
  • Elevated blood neutrophil-to-lymphocyte ratio: A readily available biomarker associated with death due to disease in high risk nonmetastatic melanoma
    Journal Article

    Davis, J. L.; Langan, R. C.; Panageas, K. S.; Zheng, J.; Postow, M. A.; Brady, M. S.; Ariyan, C.; Coit, D. G.
    Annals of Surgical Oncology (2017)

    Fulltext@MSK | Save
  • Neutrophil to lymphocyte ratio is associated with outcome during ipilimumab treatment
    Journal Article

    Cassidy, M. R.; Wolchok, R. E.; Zheng, J.; Panageas, K. S.; Wolchok, J. D.; Coit, D.; Postow, M. A.; Ariyan, C.
    EBioMedicine (2017)

    Fulltext@MSK | Save
  • Patterns and timing of initial relapse in pathologic stage II melanoma patients
    Journal Article

    Lee, A. Y.; Droppelmann, N.; Panageas, K. S.; Zhou, Q.; Ariyan, C. E.; Brady, M. S.; Chapman, P. B.; Coit, D. G.
    Annals of Surgical Oncology (2017)

    Fulltext@MSK | Save
  • Neutrophil to lymphocyte ratio to predict outcome during ipilimumab treatment
    Meeting Abstract

    Cassidy, M. R.; Wolchok, R.; Zheng, J.; Panageas, K.; Wolchok, J. D.; Coit, D. G.; Postow, M. A.; Ariyan, C. E.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Prognosis of mucosal, uveal, acral, nonacral cutaneous, and unknown primary melanoma from the time of first metastasis
    Journal Article

    Kuk, D.; Shoushtari, A. N.; Barker, C. A.; Panageas, K. S.; Munhoz, R. R.; Momtaz, P.; Ariyan, C. E.; Brady, M. S.; Coit, D. G.; Bogatch, K.; more...
    The Oncologist (2016)

    Fulltext@MSK | Save
  • Patterns and timing of first relapse in pathologic stage II melanoma patients
    Meeting Abstract

    Droppelmann, N.; Lee, A. Y.; Panageas, K.; Ariyan, C. E.; Brady, M. S.; Balakrishna, S.; Coit, D. G.
    Annals of Surgical Oncology (2016)

    Fulltext@MSK | Save
  • Elevated blood neutrophil-to-lymphocyte ratio is associated with poor survival in melanoma
    Meeting Abstract

    Davis, J.; Panageas, K.; Postow, M.; Brady, M. S.; Ariyan, C. E.; Coit, D.
    Annals of Surgical Oncology (2015)

    Fulltext@MSK | Save
  • Safety and clinical activity of combining systemic ipilimumab with isolated limb infusion in patients with in-transit melanoma
    Meeting Abstract

    Ariyan, C. E.; Lefkowitz, R. A.; Panageas, K.; Callahan, M. K.; Misholy, O.; Bello, D.; Fisher, C.; Kotin, A.; Siegelbaum, R.; Coit, D. G.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save